The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Open accessAbstract
Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-like cells. Despite the relative frequency of IH and the potential severity of complications, there are currently no uniform guidelines for treatment. Although propranolol has rapidly been adopted, there is significant uncertainty and divergence of opinion regarding safety monitoring, dose escalation, and its use in PHACE syndrome (PHACE = posterior fossa, hemangioma, arterial lesions, cardiac abnormalities, eye abnormalities; a cutaneous neurovascular syndrome characterized by large, segmental hemangiomas of the head and neck along with congenital anomalies of the brain, heart, eyes and/or chest wall). A consensus conference was held on December 9, 2011. The multidisciplinary team reviewed existing data on the pharmacologic properties of propranolol and all published reports pertaining to the use of propranolol in pediatric patients. Workgroups were assigned specific topics to propose protocols on the following subjects: contraindications, special populations, pretreatment evaluation, dose escalation, and monitoring. Consensus protocols were recorded during the meeting and refined after the meeting. When appropriate, protocol clarifications and revision were made and agreed upon by the group via teleconference. Because of the absence of high-quality clinical research data, evidence-based recommendations are not possible at present. However, the team agreed on a number of recommendations that arose from a review of existing evidence, including when to treat complicated IH; contraindications and pretreatment evaluation protocols; propranolol use in PHACE syndrome; formulation, target dose, and frequency of propranolol; initiation of propranolol in infants; cardiovascular monitoring; ongoing monitoring; and prevention of hypoglycemia. Where there was considerable controversy, the more conservative approach was selected. We acknowledge that the recommendations are conservative in nature and anticipate that they will be revised as more data are made available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Propranolol for Severe Hemangiomas of Infancy
Léauté-Labrèze, C., de la Roque, E. D., Hubiche, T., Boralevi, F., Thambo, J.-B., & Taïeb, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0708819 · Cited by 2,374
Haggstrom, A. N., Drolet, B. A., Baselga, E., Chamlin, S. L., Garzon, M. C., Horii, K. A., Lucky, A. W., Mancini, A. J., Metry, D. W., Newell, B., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0413 · Cited by 619
Self-citationPropranolol for Severe Infantile Hemangiomas: Follow-Up Report
Sans, V., de la Roque, E. D., Berge, J., Grenier, N., Boralevi, F., Mazereeuw-Hautier, J., Lipsker, D., Dupuis, E., Ezzedine, K., Vergnes, P., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-3458 · Cited by 568
Storch, C. H., & Hoeger, P. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09848.x · Cited by 526
Congenital complete heart block: an international study of the natural history.
Michaëlsson, M., & Engle, M. A. (1972) · PubMed · Cited by 406
Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations
Lawley, L. P., Siegfried, E. C., & Todd, J. L. (2009) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.00975.x · Cited by 307
A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas
Hogeling, M., Adams, S., & Wargon, O. (2011) · Pediatrics · doi:10.1542/peds.2010-0029 · Cited by 283
Complications of Systemic Corticosteroid Therapy for Problematic Hemangioma
Boon, L. M., MacDonald, D. M., & Mulliken, J. B. (1999) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-199911000-00002 · Cited by 276
Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center
Buckmiller, L. M., Munson, P. D., Dyamenahalli, U., Dai, Y., & Richter, G. T. (2010) · The Laryngoscope · doi:10.1002/lary.20807 · Cited by 203
Cited by
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
Léauté-Labrèze, C., Hoeger, P., Mazereeuw-Hautier, J., Guibaud, L., Baselga, E., Posiunas, G., Phillips, R. J., Caceres, H., Lopez Gutierrez, J. C., Ballona, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404710 · Cited by 801
Self-citationClinical Practice Guideline for the Management of Infantile Hemangiomas
Krowchuk, D. P., Frieden, I. J., Mancini, A. J., Darrow, D. H., Blei, F., Greene, A. K., Annam, A., Baker, C. N., Frommelt, P. C., Hodak, A., et al. (2019) · Pediatrics · doi:10.1542/peds.2018-3475 · Cited by 503
Self-citationDiagnosis and Management of Infantile Hemangioma
Darrow, D. H., Greene, A. K., Mancini, A. J., Nopper, A. J., the SECTION ON DERMATOLOGY, S. O. O. A. N. S., Antaya, R. J., Cohen, B., Drolet, B. A., Fay, A., Fishman, S. J., et al. (2015) · Pediatrics · doi:10.1542/peds.2015-2485 · Cited by 293
Self-citation
Metadata
- Authors
- Drolet, B. A., Frommelt, P. C., Chamlin, S. L., Haggstrom, A., Bauman, N. M., Chiu, Y. E., Chun, R. H., Garzon, M. C., Holland, K. E., Liberman, L., MacLellan-Tobert, S., Mancini, A. J., Metry, D., Puttgen, K. B., Seefeldt, M., Sidbury, R., Ward, K. M., Blei, F., Baselga, E., Cassidy, L., Darrow, D. H., Joachim, S., Kwon, E.-K. M., Martin, K., Perkins, J., Siegel, D. H., Boucek, R. J., & Frieden, I. J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2013-01-01
- Volume
- 131
- Issue
- 1
- Pages
- 128-140
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2155414885
- Cited by
- 591
- References
- 29
- FWCI
- 48.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.